Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer

[21] Okamoto S(2008)SPP1 polymorphisms associated with HBV clearance and HCC occurrence Helicobacter 13 49-55

[22] Yamamoto S(2004)An evaluation of a serologic test with a current infection maker of Helicobacter pylori before and after eradication therapy in Chinses J Surg Res 121 228-241

[23] Matsumura N(2006)The role of osteopontin in tumor metastasis Cancer Metast Rev 25 589-600

[24] Yamaquchi S(2006)Regulatory roles of Runx2 in metastatic tumor and cancer cell interaction with bone Cytokine Growth Factor Reviews 17 463-474

[25] Yamakido M(2009)Review: The regulation and role of osteopontin in malignant transformation and cancer J Cell Mol Med 13 1706-1718

[26] Taniyama K(1998)Osteopontin promotes gastric cancer metastasjs by augmenting cell suvival and invasion through Akt-mediated HIF-1 up-regulation and MMP9 activation Int J Cancer 79 127-132

[27] Sasaki N(1994)Co-expression of osteopontin and CD44v9 in gastric cancer Am J Pathol 145 610-623

[28] Schlemper RJ(2006)Osteopontin expression and distribution in human carcinomas Mol Immunol 43 980-986

[29] Torre GL(2008)A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression Mol Carcing 48 14-23

[30] Boccia S(2001)The funtional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor J Hum Genet 46 544-546

[21] Okamoto S(2008)SPP1 polymorphisms associated with HBV clearance and HCC occurrence Helicobacter 13 49-55

[22] Yamamoto S(2004)An evaluation of a serologic test with a current infection maker of Helicobacter pylori before and after eradication therapy in Chinses J Surg Res 121 228-241

[23] Matsumura N(2006)The role of osteopontin in tumor metastasis Cancer Metast Rev 25 589-600

[24] Yamaquchi S(2006)Regulatory roles of Runx2 in metastatic tumor and cancer cell interaction with bone Cytokine Growth Factor Reviews 17 463-474

[25] Yamakido M(2009)Review: The regulation and role of osteopontin in malignant transformation and cancer J Cell Mol Med 13 1706-1718

[26] Taniyama K(1998)Osteopontin promotes gastric cancer metastasjs by augmenting cell suvival and invasion through Akt-mediated HIF-1 up-regulation and MMP9 activation Int J Cancer 79 127-132

[27] Sasaki N(1994)Co-expression of osteopontin and CD44v9 in gastric cancer Am J Pathol 145 610-623

[28] Schlemper RJ(2006)Osteopontin expression and distribution in human carcinomas Mol Immunol 43 980-986

[29] Torre GL(2008)A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression Mol Carcing 48 14-23

[30] Boccia S(2001)The funtional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor J Hum Genet 46 544-546